E-LIB Suche - Ergebnisse für: Smrekar, Nataša

1

Biological treatment approach to inflammatory bowel disease..:

Tepeš, Katja ; Hanžel, Jurij ; Štubljar, David...
European Journal of Gastroenterology & Hepatology. 36 (2024) 6 - p. 728-734 , 2024

Link: https://doi.org/10.1097/..

2

Remission Is Maintained after Switch from Dose-Optimised In..:

Pintar, Špela ; Hanžel, Jurij ; Drobne, David...
Medicina. 60 (2024) 2 - p. 296 , 2024

Link: https://doi.org/10.3390/..

3

Insights into treatment of complex Crohn's perianal fistula:

Norčič, Gregor ; Smrekar, Nataša ; Marković, Srđan...
BMC Proceedings. 18 (2024) S7 - p. , 2024

Link: https://doi.org/10.1186/..

4

Ustekinumab Dosing Individualization in Crohn's Disease Gui..:

Aguiar Zdovc, Jurij ; Hanžel, Jurij ; Kurent, Tina...
Pharmaceutics. 13 (2021) 10 - p. 1587 , 2021

Link: https://doi.org/10.3390/..

5

IgA Nephropathy in a Patient Treated with Adalimumab:

Mertelj, Tonja ; Smrekar, Nataša ; Kojc, Nika..
Case Reports in Nephrology and Dialysis. 11 (2021) 2 - p. 233-240 , 2021

Link: https://doi.org/10.1159/..

6

Early vedolizumab trough levels predict combined endoscopic..:

Hanžel, Jurij ; Sever, Nejc ; Ferkolj, Ivan...
United European Gastroenterology Journal. 7 (2019) 6 - p. 741-749 , 2019

Link: https://doi.org/10.1177/..

7

Optimised infliximab monotherapy is as effective as optimis..:

Drobne, David ; Kurent, Tina ; Golob, Saša...
Alimentary Pharmacology & Therapeutics. 49 (2019) 7 - p. 880-889 , 2019

Link: https://doi.org/10.1111/..

8

Mo1836 - Vedolizumab Trough Levels at Week 6 Predict Endosc..:

Hanzel, Jurij ; Sever, Nejc ; Ferkolj, Ivan...
Gastroenterology. 154 (2018) 6 - p. S-819 , 2018

Link: https://doi.org/10.1016/..

9

Dendritic cell profiles in the inflamed colonic mucosa pred..:

Smrekar, Natasa ; Drobne, David ; Smid, Lojze M....
Radiology and Oncology. 52 (2018) 4 - p. 443-452 , 2018

Link: https://doi.org/10.2478/..

10

Comparison of radon doses based on different radon monitori..:

Vaupotič, Janja ; Smrekar, Nataša ; Žunić, Zora S.
Journal of Environmental Radioactivity. 169-170 (2017) - p. 19-26 , 2017

Link: https://doi.org/10.1016/..

11

Sa1980 High Infliximab Trough Levels Are Associated With Be..:

Drobne, David ; Kurent, Tina ; Rajar, Polona...
Gastroenterology. 150 (2016) 4 - p. S422-S423 , 2016

Link: https://doi.org/10.1016/..

12

Ustekinumab Dosing Individualization in Crohn's Disease Gui..:

Zdovc, Jurij Aguiar ; Hanzel, Jurij ; Kurent, Tina...
Pharmaceutics, 1999-4923, 2021, 13:10,. , 2021

Link: http://urn.kb.se/resolve..

13

Ustekinumab Dosing Individualization in Crohn's Disease Gui..:

Aguiar Zdovc, Jurij ; Hanžel, Jurij ; Kurent, Tina...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8538292/. , 2021

Link: http://www.ncbi.nlm.nih...

14

IgA Nephropathy in a Patient Treated with Adalimumab:

Mertelj, Tonja ; Smrekar, Nataša ; Kojc, Nika..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8436610/. , 2021

Link: http://www.ncbi.nlm.nih...

15

Early vedolizumab trough levels predict combined endoscopic..:

Hanžel, Jurij ; Sever, Nejc ; Ferkolj, Ivan...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6620872/. , 2019

Link: http://www.ncbi.nlm.nih...